Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Ramona Vladea, Remo Panaccione, Walter Reinisch, W. Rachel Duan et al.
Citations
1 citations
Journal
Journal of Crohn s and Colitis
Topics
Inflammatory Bowel Disease
Field-Weighted Citation Impact (FWCI)
1.82
article
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis
Ramona Vladea, Remo Panaccione, Walter Reinisch, W. Rachel Duan, Dolly Sharma, David T. Rubin, Jasmina Kalabic, Edward V. Loftus, Patrick Hecht, Yafei Zhang, Stefan Schreiber, Edouard Louis, Elena Marced Barrachina
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Crohn s and ColitisVol. 19(4)
Institutions
Mayo Clinic (US), University of Calgary (CA), Ludwigshafen University of Business and Society (DE), AbbVie (United States) (US), Christian-Albrechts-Universität zu Kiel (DE), University of Chicago (US), University Hospital Schleswig-Holstein (DE), Mayo Clinic in Arizona (US), AbbVie (Germany) (DE), Klinikum Ludwigshafen (DE), Centre Hospitalier Universitaire de Liège (BE), Medical University of Vienna (AT), University of Lübeck (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis — Ramona Vladea, Remo Panaccione, et al. · Journal of Crohn s and Colitis (2025) | TGRS Research Map | TGRS